Cargando…
High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 defi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493381/ https://www.ncbi.nlm.nih.gov/pubmed/28665968 http://dx.doi.org/10.1371/journal.pone.0180279 |
_version_ | 1783247495171670016 |
---|---|
author | Suzuki, Kaoru Yamada, Kenichiro Fukuhara, Yayoi Tsuji, Ai Shibata, Katsumi Wakamatsu, Nobuaki |
author_facet | Suzuki, Kaoru Yamada, Kenichiro Fukuhara, Yayoi Tsuji, Ai Shibata, Katsumi Wakamatsu, Nobuaki |
author_sort | Suzuki, Kaoru |
collection | PubMed |
description | SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease. |
format | Online Article Text |
id | pubmed-5493381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54933812017-07-18 High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice Suzuki, Kaoru Yamada, Kenichiro Fukuhara, Yayoi Tsuji, Ai Shibata, Katsumi Wakamatsu, Nobuaki PLoS One Research Article SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease. Public Library of Science 2017-06-30 /pmc/articles/PMC5493381/ /pubmed/28665968 http://dx.doi.org/10.1371/journal.pone.0180279 Text en © 2017 Suzuki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Suzuki, Kaoru Yamada, Kenichiro Fukuhara, Yayoi Tsuji, Ai Shibata, Katsumi Wakamatsu, Nobuaki High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title | High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title_full | High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title_fullStr | High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title_full_unstemmed | High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title_short | High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice |
title_sort | high-dose thiamine prevents brain lesions and prolongs survival of slc19a3-deficient mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493381/ https://www.ncbi.nlm.nih.gov/pubmed/28665968 http://dx.doi.org/10.1371/journal.pone.0180279 |
work_keys_str_mv | AT suzukikaoru highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice AT yamadakenichiro highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice AT fukuharayayoi highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice AT tsujiai highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice AT shibatakatsumi highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice AT wakamatsunobuaki highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice |